Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.37 $15.43 Thursday, 9th May 2024 URGN stock ended at $12.97. This is 2.26% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 4.81% from a day low at $12.60 to a day high of $13.21.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Nov 22, 2017 $40.90 $40.93 $40.13 $40.18 113 762
Nov 21, 2017 $41.50 $41.85 $40.50 $40.91 115 426
Nov 20, 2017 $39.66 $42.67 $39.65 $41.80 349 583
Nov 17, 2017 $39.69 $42.16 $39.69 $41.00 176 311
Nov 16, 2017 $41.00 $41.69 $39.82 $40.25 276 126
Nov 15, 2017 $41.10 $42.20 $39.52 $41.56 116 769
Nov 14, 2017 $43.50 $43.50 $41.05 $42.18 127 121
Nov 13, 2017 $41.51 $44.63 $41.37 $43.26 154 844
Nov 10, 2017 $38.55 $41.40 $38.24 $41.04 150 859
Nov 09, 2017 $38.25 $39.00 $37.27 $38.26 141 350
Nov 08, 2017 $37.73 $38.56 $36.74 $38.20 355 417
Nov 07, 2017 $36.80 $37.44 $35.50 $37.15 235 270
Nov 06, 2017 $36.80 $37.36 $31.60 $36.82 378 663
Nov 03, 2017 $33.91 $38.38 $33.81 $36.82 157 364
Nov 02, 2017 $31.68 $33.98 $31.53 $33.79 58 462
Nov 01, 2017 $31.70 $32.22 $29.72 $32.08 136 159
Oct 31, 2017 $30.66 $32.80 $26.50 $31.73 154 504
Oct 30, 2017 $28.40 $32.00 $28.40 $30.66 52 665
Oct 27, 2017 $27.63 $28.85 $26.52 $28.42 20 537
Oct 26, 2017 $28.29 $28.29 $26.50 $27.55 36 771
Oct 25, 2017 $30.28 $30.28 $27.56 $28.55 38 628
Oct 24, 2017 $27.38 $30.39 $27.01 $29.45 52 143
Oct 23, 2017 $27.45 $27.75 $25.56 $27.34 64 511
Oct 20, 2017 $27.50 $27.59 $26.77 $27.28 19 984
Oct 19, 2017 $27.34 $27.92 $26.76 $27.46 27 079
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT